Choice of anticoagulant for treatment of pulmonary embolism
 • Malignancy - LMWH
 • To avoid parenteral therapy - Rivaroxaban; apixaban
 • Once a day oral therapy - Rivaroxaban; edoxaban; VKA
 • Hepatic involvement with coagulopathy - LMWH
 • Renal involvement with creatinine clearance <30 mL/min - VKA
 • Dyspepsia or history of Gl bleed - VKA, apixaban
 • Thrombolyzed patients - UFH
 • Need of reversal agent - VKA, UFH
 • Pregnancy - LMWH

#anticoagulant #selection #decisionaid #vte #anticoagulation #pharmacology